2019 - Priestley Soundy

PriestleySoundy advises Stephan Wilcke with his appointment as senior independent Non-executive director of Equiom

  PriestleySoundy advised Stephan Wilcke in connection with his appointment as the senior independent Non-executive Director of Equiom. In May 2019, Varde announced its investment in Equiom as a long-term equity partner to help fund future expansion in line with the Company’s growth strategy.  Varde joined Equiom’s longstanding equity partner LDC, which has supported Equiom’s

Read More...

PriestleySoundy advises Senior Management Team of Care UK Health Care

PriestleySoundy advised the Senior Management Team of Care UK Health Care in connection with their incentive arrangements. Care UK Health Care is England’s largest independent provider of NHS services, delivering more than 70 different healthcare services throughout the UK.  Founded in 1982, Care UK’s healthcare services include treatment centres, GP practices, NHS walk-in centres, GP

Read More...

PriestleySoundy advises international Senior Management Team of Refinitiv

PriestleySoundy is advising the international (including UK and US Managers) Senior Management Team of Refinitiv in connection with the proposed £22bn (US $27bn) acquisition of their business by The London Stock Exchange Group (LSEG).  The transaction, which is conditional on LSEG shareholder and regulatory approval, is expected to close in the second half of 2020.

Read More...

PriestleySoundy advises Senior Management of Acuris on its sale to ION Investment Group

PriestleySoundy has advised the international (UK and US) Senior Management of Acuris in connection with the sale of a majority stake of the business to ION Investment Group for a reported £1.35bn (US $2.39bn). Founded in 2000 and with nearly 1,500 employees in 66 locations worldwide, Acuris (formerly known as Mergermarket Group) provides proprietary, actionable

Read More...